In 2017, Wolfe Laboratories became a subsidiary of Pace Analytical Services, LLC, a network of full-service contract development and analytical testing laboratories.
The Senior Director, New Technologies is responsible for defining and building CMC analytical and formulation platform technologies to support Wolfe Laboratories’ (WL) clients’ emerging therapeutic modalities dosage form development. The Senior Director, New Technologies is responsible for contributing to Wolfe Laboratories’ marketing and sales strategy implementation as it relates to oligonucleotide and biologics services, will serve as subject matter expert during sales presentations, and will cultivate high value client relationships. The Senior Director, New Technologies will direct staff and oversee project management for client CMC development projects, and will monitor revenue, expenses and resource allocation.
Financial – Approximately 15%
New Technology Development – Approximately 40%
Management/Leadership – Approximately 30%
Operations – Approximately 5%
Sales – Approximately 10%